Stock listing

A2AG5N Stock Price, News, Filings & Events — Niagen Bioscience, Inc.

Selected listing: A2AG5N · LS · EUR · DE

This page tracks Niagen Bioscience, Inc.'s A2AG5N:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2AG5N:LS. A2AG5N:LS is the stock-level entry point for investors researching Niagen Bioscience, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Niagen Bioscience, Inc. (ticker: NAGE) is a publicly traded company based in America, with a market capitalization of approximately $261.2 million. The company focuses on innovative bioscience solutions. Investors can find detailed information about its operations and performance on its public company page.

A2AG5N:LSEURDEUpdated July 21, 2026
Niagen Bioscience, Inc. logo
Ticker
A2AG5N:LS
Asset type
Stock
Market cap
$261.2M
Sector
Health Technology
Industry
Pharmaceuticals: Other
Exchange
LS
Currency
EUR

Niagen Bioscience, Inc. A2AG5N:LS stock context

This page tracks Niagen Bioscience, Inc.'s A2AG5N:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2AG5N:LS. A2AG5N:LS is the stock-level entry point for investors researching Niagen Bioscience, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Niagen Bioscience, Inc. (ticker: NAGE) is a publicly traded company based in America, with a market capitalization of approximately $261.2 million. The company focuses on innovative bioscience solutions. Investors can find detailed information about its operations and performance on its public company page.

Research Niagen Bioscience, Inc.

Alternate listings